Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on Dec 14, 2022 10:41am
147 Views
Post# 35170780

RE:RE:RE:Next Week's Option Expiry

RE:RE:RE:Next Week's Option Expiry I don't understand why the options expiry would need to be extended when it was preset so far in advance before any new knowledge of anything that might persuade how you trade.  I suppose limiting the sale of the stock after option conversion would be warranted during the blackout period.  How do we verify when these blackout periods take place?

palinc2000 wrote: Come to think of it I dont think there are any SEC regulations preventing options that are about to expire to be exercised during the black out period...Recall that last year a massive amount of options were granred on DEC 1 the first day of the black out period,,,,1 am  puzzled as to the why!!!!!
Can you provide the link ?


palinc2000 wrote:

I guess that would mean sometimes in February.
The tax liability if any would be differed to April 2024 

SABBOBCAT wrote: FYI: due to being in blackout period, the option expiry has been extended until 10 days after the blackout period ends.

 





<< Previous
Bullboard Posts
Next >>